A detailed history of Hc Financial Advisors Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Hc Financial Advisors Inc holds 678 shares of ABBV stock, worth $122,040. This represents 0.07% of its overall portfolio holdings.

Number of Shares
678
Previous 578 17.3%
Holding current value
$122,040
Previous $94,000 10.64%
% of portfolio
0.07%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022

BUY
$137.62 - $174.96 $13,762 - $17,496
100 Added 17.3%
678 $104,000
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $26,395 - $32,750
200 Added 52.91%
578 $94,000
Q3 2020

Oct 30, 2020

SELL
$85.91 - $100.83 $26,374 - $30,954
-307 Reduced 44.82%
378 $33,000
Q1 2020

Apr 08, 2020

BUY
$64.5 - $97.79 $44,182 - $66,986
685 New
685 $52,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hc Financial Advisors Inc Portfolio

Follow Hc Financial Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hc Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hc Financial Advisors Inc with notifications on news.